$PBIO (September 18, 2019) - The Stock Day Podcast
Post# of 99197
(Total Views: 179)
Posted On: 09/20/2019 11:55:51 AM
$PBIO (September 18, 2019) - The Stock Day Podcast recently welcomed Mr. Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) ("the Company"
, to discuss PBIO on Stock Day with its host Mr. Everett Jolley. PBIO is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry.
Mr. Jolly began the interview by welcoming Mr. Schumacher back to the Stock Day Podcast He noted that the Company is continuing to show impressive growth while announcing a number of very impressive achievements.
Mr. Jolly commented: "It's been about six weeks since you've been on the show. During that time there have been several exciting developments at Pressure BioSciences. Please tell us about PBIO and your recent successes."
Mr. Schumacher explained that the Company has gone through substantial changes over the last 12 months. "A year ago, PBIO had one revenue-generating division. We now have three, each based on our proprietary PCT, BaroFold, or UST platforms.
Mr. Schumacher continued: "Our PCT platform supports our primary business, which is selling pressure-based instruments and consumables to research laboratories worldwide. Our customers include some of the world's foremost protein chemists, working in many of the finest academic, government, biotech, and phama laboratories around the globe. These scientists use PCT systems for a number of different protein, RNA, and DNA applications as they search to find new biomarkers of disease, diagnostic tools, druggable targets, and therapeutics."
, to discuss PBIO on Stock Day with its host Mr. Everett Jolley. PBIO is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Mr. Jolly began the interview by welcoming Mr. Schumacher back to the Stock Day Podcast He noted that the Company is continuing to show impressive growth while announcing a number of very impressive achievements.
Mr. Jolly commented: "It's been about six weeks since you've been on the show. During that time there have been several exciting developments at Pressure BioSciences. Please tell us about PBIO and your recent successes."
Mr. Schumacher explained that the Company has gone through substantial changes over the last 12 months. "A year ago, PBIO had one revenue-generating division. We now have three, each based on our proprietary PCT, BaroFold, or UST platforms.
Mr. Schumacher continued: "Our PCT platform supports our primary business, which is selling pressure-based instruments and consumables to research laboratories worldwide. Our customers include some of the world's foremost protein chemists, working in many of the finest academic, government, biotech, and phama laboratories around the globe. These scientists use PCT systems for a number of different protein, RNA, and DNA applications as they search to find new biomarkers of disease, diagnostic tools, druggable targets, and therapeutics."
(0)
(0)